8-K: Green Thumb Industries Reports Modest Revenue Growth in Q1 2025 Amidst Pricing Pressures

Green Thumb Industries announces a 1% increase in revenue to $280 million for Q1 2025, alongside a decrease in net income compared to the previous year.

Summary

• Green Thumb Industries reported its financial results for the quarter ended March 31, 2025.
• Revenue reached $280 million, a 1% increase compared to the prior year.
• GAAP net income was $8 million, or $0.04 per share.
• Adjusted EBITDA was $85 million, representing 31% of revenue.
• The company opened two new RISE Dispensaries during the quarter, one in Nevada and one in Ohio.
• Retail revenue decreased by 2.5% due to price compression in several markets.
• Comparable sales decreased by 5.3% across 90 stores open for at least 12 months.
• Consumer Packaged Goods revenue increased by 13.6% due to growth in existing markets and the addition of adult-use sales in Ohio.
• Gross profit was $143.3 million, or 51.3% of revenue, compared to $144.9 million, or 52.5% of revenue in the prior year.
• Selling, general, and administrative expenses increased to $100.8 million, or 36.1% of revenue.
• Cash and cash equivalents totaled $210.6 million at the end of the quarter.
• Total debt outstanding was $252.4 million.
• The company repurchased approximately 160,000 Subordinate Voting Shares for approximately $1 million during the quarter.
• The company anticipates ongoing near-term headwinds from pricing compression, increased competition and consumer softness.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue increased, profitability declined, and the company faces headwinds. Management's comments are optimistic, but the financial results indicate challenges.

Positives

• Revenue increased to $280 million, a 1% increase year-over-year.
• The company maintains a strong cash position with $211 million in cash and cash equivalents.
• Consumer Packaged Goods revenue experienced a 13.6% increase.
• The company opened two new RISE Dispensaries, expanding its retail footprint.
• Cash flow from operations was $74 million.

Negatives

• Net income decreased from $31.1 million to $8.3 million compared to the prior year period.
• Retail revenue decreased by 2.5% due to price compression in existing markets.
• Comparable sales decreased by 5.3% across 90 stores.
• Gross profit margin decreased from 52.5% to 51.3% due to price compression.
• Selling, general, and administrative expenses increased significantly.

Risks

• The company faces ongoing near-term headwinds from pricing compression.
• Increased competition is expected to impact future performance.
• Consumer softness may affect sales and revenue.
• Cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change.
• The company operates in a highly regulated sector and may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where it conducts business.

Future Outlook

The company anticipates ongoing near-term headwinds from pricing compression, increased competition, and consumer softness, but remains confident in its ability to navigate these challenges and deliver strong results for shareholders. The company is preparing for the launch of adult-use sales in Minnesota, which is expected to commence before year end.

Management Comments

• The Green Thumb team delivered a respectable quarter with revenue and Adjusted EBITDA of $280 million and $85 million, respectively, and cash flow from operations of $74 million, said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler.
• We ended the quarter with a strong balance sheet including $211 million in cash, said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler.
• We are off to a great start in 2025, said Green Thumb President Anthony Georgiadis.

Industry Context

The cannabis industry is facing increasing competition and pricing pressures, impacting revenue and profitability. Green Thumb's results reflect these broader industry trends, with the company focusing on expanding its brand presence and retail footprint to maintain its market position.

Comparison to Industry Standards

• Comparing Green Thumb's 1% revenue growth to other multi-state operators (MSOs) like Curaleaf, Trulieve, and Cresco Labs, which have also reported varying degrees of growth and challenges in the current market, provides context.
• While some companies are experiencing higher growth rates in specific markets, the overall trend indicates a slowdown in revenue growth across the industry due to market saturation and regulatory hurdles.
• Green Thumb's Adjusted EBITDA margin of 31% is within the range of other leading MSOs, but the decrease from the prior year suggests increasing cost pressures.
• Companies like Trulieve, known for their strong presence in Florida, often report higher margins due to favorable market conditions and vertical integration.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and the impact of pricing compression.
• Employees may face uncertainty due to potential cost-cutting measures to address profitability challenges.
• Customers may benefit from lower prices due to increased competition and price compression.
• Suppliers may experience pressure on pricing due to the company's focus on cost management.

Next Steps

• The company is preparing for the launch of adult-use sales in Minnesota before the end of the year.
• Green Thumb will continue to focus on expanding its brand presence and retail footprint.
• The company will host a conference call on May 7, 2025, to discuss the results.

Key Dates

Keywords

Green Thumb Industries, cannabis, financial results, Q1 2025, revenue, EBITDA, RISE Dispensaries, retail, CPG, net income